Anaphylaxis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Investigational therapy for anaphylaxis include various forms of immunotherapy and monoclonal antibodies. <ref name="pmid21682750">{{cite journal| author=Boden SR, Wesley Burks A| title=Anaphylaxis: a history with emphasis on food allergy. | journal=Immunol Rev | year= 2011 | volume= 242 | issue= 1 | pages= 247-57 | pmid=21682750 | doi=10.1111/j.1600-065X.2011.01028.x | pmc=3122150 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21682750 }} </ref> | |||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
Revision as of 09:21, 15 April 2021
|
Anaphylaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anaphylaxis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Anaphylaxis future or investigational therapies |
|
Risk calculators and risk factors for Anaphylaxis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Investigational therapy for anaphylaxis include various forms of immunotherapy and monoclonal antibodies. [1]
Future or Investigational Therapies
References
- ↑ Boden SR, Wesley Burks A (2011). "Anaphylaxis: a history with emphasis on food allergy". Immunol Rev. 242 (1): 247–57. doi:10.1111/j.1600-065X.2011.01028.x. PMC 3122150. PMID 21682750.